These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 527636)

  • 1. Plasma protein binding of prednisolone in normal volunteers and arthritic patients.
    Ağabeyoğlu IT; Bergstrom RF; Gillespie WR; Wagner JG; Kay DR
    Eur J Clin Pharmacol; 1979; 16(6):399-404. PubMed ID: 527636
    [No Abstract]   [Full Text] [Related]  

  • 2. The nonlinear pharmacokinetics of prednisone and prednisolone. II. Plasma protein binding of prednisone and prednisolone in rabbit and human plasma.
    Ferry JJ; Wagner JG
    Biopharm Drug Dispos; 1987; 8(3):261-72. PubMed ID: 3593903
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determination of prednisolone and prednisone in plasma, whole blood, urine, and bound-to-plasma proteins by high-performance liquid chromatography.
    Gai MN; Pinilla E; Paulos C; Chávez J; Puelles V; Arancibia A
    J Chromatogr Sci; 2005 Apr; 43(4):201-6. PubMed ID: 15975236
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prednisolone protein binding in renal transplant patients.
    Reece PA; Disney AP; Stafford I; Shastry JC
    Br J Clin Pharmacol; 1985 Aug; 20(2):159-62. PubMed ID: 3899153
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of prednisone and hydrocortisone on the plasma protein binding of prednisolone in man.
    Legler UF; Benet LZ
    Eur J Clin Pharmacol; 1986; 30(1):51-5. PubMed ID: 3709632
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma protein binding interaction of prednisone and prednisolone.
    Boudinot FD; Jusko WJ
    J Steroid Biochem; 1984 Sep; 21(3):337-9. PubMed ID: 6492791
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alterations in prednisolone disposition as a result of time of administration, gender and dose.
    Meffin PJ; Brooks PM; Sallustio BC
    Br J Clin Pharmacol; 1984 Apr; 17(4):395-404. PubMed ID: 6721985
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Measurement of plasma prednisolone in man.
    Wilson CG; Ssendagire R; May CS; Paterson JW
    Br J Clin Pharmacol; 1975 Aug; 2(4):321-5. PubMed ID: 1233991
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prednisolone disposition and protein binding in oral contraceptive users.
    Boekenoogen SJ; Szefler SJ; Jusko WJ
    J Clin Endocrinol Metab; 1983 Apr; 56(4):702-9. PubMed ID: 6833459
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estimation of transcortin concentration by measurements of plasma protein-binding of prednisolone and by electroimmunodiffusion.
    Frey BM; Frey FJ
    Br J Clin Pharmacol; 1982 Feb; 13(2):245-9. PubMed ID: 6800390
    [No Abstract]   [Full Text] [Related]  

  • 11. Prednisolone binding to plasma proteins in domestic species.
    Alvinerie M; Houin G; Toutain PL
    J Pharm Sci; 1988 Nov; 77(11):937-8. PubMed ID: 3225753
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blood collection technique: no effect on in vitro protein binding of prednisolone.
    Rocci ML; Jusko WJ
    J Pharm Sci; 1981 Oct; 70(10):1160-1. PubMed ID: 7299653
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methylprednisolone versus prednisolone pharmacokinetics in relation to dose in adults.
    Szefler SJ; Ebling WF; Georgitis JW; Jusko WJ
    Eur J Clin Pharmacol; 1986; 30(3):323-9. PubMed ID: 3732369
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nonlinear plasma protein binding and haemodialysis clearance of prednisolone.
    Frey FJ; Gambertoglio JG; Frey BM; Benet LZ; Amend WJ
    Eur J Clin Pharmacol; 1982; 23(1):65-74. PubMed ID: 6751835
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dose dependent pharmacokinetics of prednisolone.
    Pickup ME; Lowe JR; Leatham PA; Rhind VM; Wright V; Downie WW
    Eur J Clin Pharmacol; 1977 Nov; 12(3):213-9. PubMed ID: 590308
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum protein binding of prednisolone in four species.
    Rocci ML; Johnson NF; Jusko WJ
    J Pharm Sci; 1980 Aug; 69(8):977-8. PubMed ID: 7400951
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Population pharmacokinetics of prednisolone in children with acute lymphoblastic leukemia.
    Petersen KB; Jusko WJ; Rasmussen M; Schmiegelow K
    Cancer Chemother Pharmacol; 2003 Jun; 51(6):465-73. PubMed ID: 12698270
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Absorption of enteric and non-enteric coated prednisolone tablets.
    Hulme B; James VH; Rault R
    Br J Clin Pharmacol; 1975 Aug; 2(4):317-20. PubMed ID: 1233990
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dose-dependent prednisolone kinetics.
    Tanner A; Bochner F; Caffin J; Halliday J; Powell L
    Clin Pharmacol Ther; 1979 May; 25(5 Pt 1):571-8. PubMed ID: 436359
    [No Abstract]   [Full Text] [Related]  

  • 20. Altered prednisolone kinetics in patients with the nephrotic syndrome.
    Frey FJ; Frey BM
    Nephron; 1982; 32(1):45-8. PubMed ID: 7177276
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.